Fujian Cosunter Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300436.SZ

Fujian Cosunter Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2023: USD 8.31 M

Fujian Cosunter Pharmaceutical Co., Ltd. Goodwill is USD 8.31 M for the year ending December 31, 2023, a -2.80% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • Fujian Cosunter Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2022 was USD 8.55 M, a -7.92% change year over year.
  • Fujian Cosunter Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2021 was USD 9.28 M, a 2.73% change year over year.
  • Fujian Cosunter Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2020 was USD 9.03 M, a 6.69% change year over year.
  • Fujian Cosunter Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2019 was USD 8.47 M, a -1.24% change year over year.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
SV Wall Street
Shenzhen Stock Exchange: 300436.SZ

Fujian Cosunter Pharmaceutical Co., Ltd.

CEO Mr. Guoping Li
IPO Date May 4, 2015
Location China
Headquarters Software Park, Building 10
Employees 908
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Clinical Trials
Description

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers Chinese patent medicines in the areas of liver diseases, andrology, cardiovascular, and other fields. The company was founded in 2001 and is based in Fuzhou, China.

StockViz Staff

February 2, 2025

Any question? Send us an email